Natco Pharma invests Rs 7.5 crore in Hyderabads PACE Hospital
New Delhi: Natco Pharma said it has invested Rs 7.5 crore to pick up 7.5 percent stake in OMRV Hospitals.
"NATCO Pharma Ltd would like to announce that today it has executed a definitive agreement and subscribed to 7.5 percent of the paid-up equity share capital of OMRV Hospitals," it said in a BSE filing.
It added that the investment amount was Rs 7.50 crore for the transaction.
OMRV operates under the brand name 'PACE Hospital', which is a super specialty hospital presently operating in Hyderabad, Telangana.
The hospital focuses on tertiary care services in the field of medical and surgical gastroenterology, hepatology, nephrology, urology, GI oncology, and andrology.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd